Company / FCF Margin
Co-Diagnostics, Inc. FCF Margin History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-4793.2%
FY2025
5-year range
-4793.2% / 41.3%
FY2021-FY2025
Trend
-527.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin changed -528% YoY in FY2025, a notable deviation from the 8-year average annual change of -184%.
Based on SEC 10-K filings.
-4793.2% in FY2025 with a 5-year CAGR of -2170.4%.
Declined from -344.2% to -4793.2% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -4834.4pp
- 5-Year Change
- -2170.4pp
- 10-Year Change
- -
Key checks
Key Insights
- Co-Diagnostics, Inc.'s fcf margin has declined for 3 consecutive years.
- In FY2025, fcf margin decreased 527.6% year-over-year.
- Peak fcf margin was recorded in FY2022.
- Lowest fcf margin in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -4793.2% | -527.6% |
| FY2024 | -763.8% | -121.9% |
| FY2023 | -344.2% | -933.8% |
| FY2022 | 41.3% | +12.4% |
| FY2021 | 36.7% | +101.4% |
| FY2020 | -2622.8% | +74.6% |
| FY2019 | -10326.4% | +76.3% |
| FY2018 | -43601.0% | -152.2% |
| FY2017 | -17286.7% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026